Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carlyle Europe Technology Partners is Carlyle's European technology-focused private equity investment strategy rather than an operating life sciences or healthcare company. It invests in lower mid-market and growth technology companies across Europe, with a focus on software, technology-enabled services, telecommunications, and related sectors. Public references describe CETP as a Carlyle-managed fund family that has included vehicles such as CETP IV and CETP V. While some portfolio companies may serve healthcare or biopharma customers, CETP itself does not develop therapeutics, diagnostics, or healthcare products. For biotech analyst purposes, this entity should be classified as an investor, not a drug developer or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carlyle Europe Technology Partners.